Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (61-70 of 170) with videos related to

Pageof 17
Sort By:
Cancer Causes & Control : CCC|March 12, 2026
Addressing pancreatic cancer disparities in Oregon's Native American population via tribally responsive research systems with the confederated tribes of warm springsJared Delaney, Lonnie James, Paige E Farris, et al.
Cell Cycle (Georgetown, Tex.)|September 20, 2008
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcomeAgnieszka K Witkiewicz, Katherine H Nguyen, Abhijit Dasgupta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2007
Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasiaJonathan R Brody, Agnes Witkiewicz, Timothy K Williams, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2015
Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assaysJoseph A Cozzitorto, Masaya Jimbo, Saswati Chand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2009
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinomaJonathan R Brody, Christina L Costantino, Magdalena Potoczek, et al.
Cancers|April 12, 2022
HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) IsoformsAditi Jain, Matthew McCoy, Carolyn Coats, et al.
Cancer Biology & Therapy|June 25, 2010
Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrenceAgnieszka K Witkiewicz, Boris Freydin, Inna Chervoneva, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
The RNA-binding protein HuR impairs adipose tissue anabolism in pancreatic cancer cachexiaPaige C Arneson-Wissink, Katherine Pelz, Beth Worley, et al.
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
BMC Cancer|March 23, 2012
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Matias E Valsecchi, Thomas Holdbrook, Benjamin E Leiby, et al.
Pageof 17

Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Cancer Causes & Control : CCC|March 12, 2026
Addressing pancreatic cancer disparities in Oregon's Native American population via tribally responsive research systems with the confederated tribes of warm springsJared Delaney, Lonnie James, Paige E Farris, et al.
Cell Cycle (Georgetown, Tex.)|September 20, 2008
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcomeAgnieszka K Witkiewicz, Katherine H Nguyen, Abhijit Dasgupta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2007
Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasiaJonathan R Brody, Agnes Witkiewicz, Timothy K Williams, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2015
Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assaysJoseph A Cozzitorto, Masaya Jimbo, Saswati Chand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2009
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinomaJonathan R Brody, Christina L Costantino, Magdalena Potoczek, et al.
Cancers|April 12, 2022
HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) IsoformsAditi Jain, Matthew McCoy, Carolyn Coats, et al.
Cancer Biology & Therapy|June 25, 2010
Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrenceAgnieszka K Witkiewicz, Boris Freydin, Inna Chervoneva, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
The RNA-binding protein HuR impairs adipose tissue anabolism in pancreatic cancer cachexiaPaige C Arneson-Wissink, Katherine Pelz, Beth Worley, et al.
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
BMC Cancer|March 23, 2012
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Matias E Valsecchi, Thomas Holdbrook, Benjamin E Leiby, et al.
Pageof 17